Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times.
Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times.
复制标题
DOI:
10.3390/ijerph19148883
复制
发表时间:
2022-07-21
影响因子:
--
通讯作者:
Borquez, Annick
中科院分区:
文献类型:
--
作者:
Vo, Anh Truc;Patton, Thomas;Peacock, Amy;Larney, Sarah;Borquez, Annick
We carried out a scoping review to characterize the primary quantitative evidence addressing changes in key individual/structural determinants of substance use risks and health outcomes over the first two waves of the COVID-19 pandemic in the United States (US). We systematically queried the LitCovid database for US-only studies without date restrictions (up to 6 August 2021). We extracted quantitative data from articles addressing changes in: (a) illicit substance use frequency/contexts/behaviors, (b) illicit drug market dynamics, (c) access to treatment and harm reduction services, and (d) illicit substance use-related health outcomes/harms. The majority of 37 selected articles were conducted within metropolitan locations and leveraged historical timeseries medical records data. Limited available evidence supported changes in frequency/behaviors/contexts of substance use. Few studies point to increases in fentanyl and reductions in heroin availability. Policy-driven interventions to lower drug use treatment thresholds conferred increased access within localized settings but did not seem to significantly prevent broader disruptions nationwide. Substance use-related emergency medical services’ presentations and fatal overdose data showed a worsening situation. Improved study designs/data sources, backed by enhanced routine monitoring of illicit substance use trends, are needed to characterize substance use-related risks and inform effective responses during public health emergencies.
登录
查看更多内容
DOI:
10.1016/j.drugpo.2021.103199
发表时间:
2021-08
期刊:
The International journal on drug policy
影响因子:
--
作者:
French R;Favaro J;Aronowitz SV
通讯作者:
Aronowitz SV
影响因子:
3.9
作者:
Brothers, Sarah;Viera, Adam;Heimer, Robert
通讯作者:
Heimer, Robert
DOI:
10.1186/s13011-021-00395-6
发表时间:
2021-08-09
期刊:
Substance abuse treatment, prevention, and policy
影响因子:
--
作者:
Alexander K;Pogorzelska-Maziarz M;Gerolamo A;Hassen N;Kelly EL;Rising KL
通讯作者:
Rising KL
影响因子:
4.2
作者:
Janulis P;Newcomb ME;Mustanski B
通讯作者:
Mustanski B
影响因子:
5.7
作者:
Caton L;Cheng H;Garneau HC;Fisher T;Harris-Mills B;Hurley B;Newman S;McGovern MP
通讯作者:
McGovern MP